Phase II study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindesine for unresectable stage III non-small-cell lung cancer: Japan Clinical Oncology Group Study 9306
Ikuo Sekine, Yutaka Nishiwaki, Takashi Ogino, Akira Yokoyama, Mari Saito, Kiyoshi Mori, Iwao Tsukiyama, Satoshi Tsuchiya, Kazushige Hayakawa, Kimio Yoshimura, Naoki Ishizuka, Nagahiro Saijo
研究成果: Article › 査読
4
被引用数
(Scopus)